NCT02663960View on ClinicalTrials.gov

Compare Efficacy and Simplicity of Regional Citrate Anticoagulation With Fixed Dose Versus Adjusted Citrate Program

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Critical IllnessKidney Replacement DisorderCoagulation; Intravascular
Interventions
OTHER

fixed citrate doses protocol

fixed doses of anticoagulant citrate dextrose solution to meet a circuit citrate concentration of 4 mmol/l.

OTHER

adjusted citrate doses protocol

the starting infusion rate of anticoagulant citrate dextrose solution be set 2.5 % of blood flow and then be adjusted to obtain postfilter ionized calcium levels of less than 0.40 mmol/l.

Trial Locations (1)

100730

MICU of Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT02663960 - Compare Efficacy and Simplicity of Regional Citrate Anticoagulation With Fixed Dose Versus Adjusted Citrate Program | Biotech Hunter | Biotech Hunter